Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells

Toxicology

Volumn 279, Issue 1-3, 2011, Pages 146-154

  Procházková, Jiřina ^a,b   Kozubík, Alois ^a   Machala, Miroslav ^b   Vondráček, Jan ^a,b  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b VETERINARY RESEARCH INSTITUTE   (Czech Republic)

Author keywords

Aryl hydrocarbon receptor; Cell cycle; Indirubin; Plakoglobin; Rat liver cells

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; INDIRUBIN; MESSENGER RNA; PLAKOGLOBIN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEGRADATION; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATOMA CELL; IMMUNOCYTOCHEMISTRY; LIVER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INDOLES; LIVER; LIVER NEOPLASMS; PROTEIN TRANSPORT; RATS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; STEM CELLS; TETRACHLORODIBENZODIOXIN;

RATTUS;

EID: 78650011767     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.10.003     Document Type: Article

References (41)

1. Andrysík Z., Vondráček J., Machala M., Krčmář P., Švihálková-Šindlerová L., Kranz A., Weiss C., Faust D., Kozubík A., Dietrich C. The aryl hydrocarbon receptor-dependent deregulation of cell cycle control induced by polycyclic aromatic hydrocarbons in rat liver epithelial cells. Mutat. Res. 2007, 615:87-97.
2. Adachi J., Mori Y., Matsui S., Matsuda T. Comparison of gene expression patterns between 2,3,7,8-tetrachlorodibenzo-p-dioxin and a natural aryl hydrocarbon receptor ligand, indirubin. Toxicol. Sci. 2004, 80:161-169.
3. Adachi J., Mori Y., Matsui S., Takigami H., Fujino J., Kitagawa H., Miller C.A., Kato T., Saeki K., Matsuda T. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 2001, 276:31475-31478.
4. Bock K.W., Köhle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 2006, 72:393-404.
5. Cowin P., Kapprell H.P., Franke W.W., Tamkun J., Hynes R.O. Plakoglobin: a protein common to different kinds of intercellular adhering junctions. Cell 1986, 46:1063-1073.
6. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 2003, 43:309-334.
7. Dietrich C., Faust D., Moskwa M., Kunz A., Bock K.W., Oesch F. TCDD-dependent downregulation of gamma-catenin in rat liver epithelial cells (WB-F344). Int. J. Cancer 2003, 103:435-439.
8. Eisenbrand G., Hippe F., Jakobs S., Muehlbeyer S. Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J. Cancer Res. Clin. Oncol. 2004, 130:627-635.
9. Göttlicher M., Cikryt P., Wiebel F.J. Inhibition of growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin in 5L rat hepatoma cells is associated with the presence of Ah receptor. Carcinogenesis 1990, 11:2205-2210.
10. Gu Y.Z., Hogenesch J.B., Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 2000, 40:519-561.
11. Guengerich F., Martin M.V., McCormick W.A., Nguyen L.P., Glover E., Bradfield C.A. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo. Arch. Biochem. Biophys. 2004, 423:309-316.
12. Henry E.C., Gasiewicz T.A. Agonist but not antagonist ligands induce conformational change in the mouse aryl hydrocarbon receptor as detected by partial proteolysis. Mol. Pharmacol. 2003, 63:392-400.
13. Hoessel R., Leclerc S., Endicott J.A., Nobel M.E., Lawrie A., Tunnah P., Leost M., Damiens E., Marie D., Marko D., Niederberger E., Tang W., Eisenbrand G., Meijer L. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat. Cell Biol. 1999, 1:60-67.
14. Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans 1997, IARC, IARC, Lyon, p. 666.
15. Kewley R.J., Whitelaw M.L., Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol. 2004, 36:189-204.
16. Knockaert M., Blondel M., Bach S., Leost M., Elbi C., Hager G.L., Nagy S.R., Han D., Denison M., Ffrench M., Ryan X.P., Magiatis P., Polychronopoulos P., Greengard P., Skaltsounis L., Meijer L. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 2004, 23:4400-4412.
17. Köhle C., Bock K.W. Coordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2. Biochem. Pharmacol. 2007, 73:1853-1862.
18. Kosmopoulou M.N., Leonidas D.D., Chrysina E.D., Bischler N., Eisenbrand G., Sakarellos C.E., Pauptit R., Oikonomakos N.G. Binding of the potential antitumour agent indirubin-5-sulphonate at the inhibitor site of rabbit muscle glycogen phosphorylase b. Comparison with ligand binding to pCDK2-cyclin A complex. Eur. J. Biochem. 2004, 271:2280-2290.
19. Leclerc S., Garnier M., Hoessel R., Marko D., Bibb J.A., Snyder G.L., Greengard P., Biernat J., Wu Y.Z., Mandelkow E.M., Eisenbrand G., Meijer L. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J. Biol. Chem. 2001, 276:251-260.
20. Lewis J.E., Wahl J.K., Sass K.M., Jensen P.J., Johnson K.R., Wheelock M.J. Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J. Cell Biol. 1997, 136:919-934.
21. Ma Q., Kinneer K., Bi Y., Chan J.Y., Kan Y.W. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem. J. 2004, 377:205-213.
22. Mandal P.K. Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J. Comp. Physiol. B 2005, 175:221-230.
23. Marchand A., Barouki R., Garlatti M. Regulation of NAD(P)H:quinone oxidoreductase 1 gene expression by CYP1A1 activity. Mol. Pharmacol. 2004, 65:1029-1037.
24. Marko D., Schatzle S., Friedel A., Genzlinger A., Zankl H., Meijer L., Eisenbrand G. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br. J. Cancer 2001, 84:283-289.
25. Miao W., Hu L., Scrivens P.J., Batist G. Transcriptional regulation of NF-E2 p45-related factor (NRF2) expression by the aryl hydrocarbon receptor-xenobiotic response element signalling pathway: direct cross-talk between phase I and II drug-metabolizing enzymes. J. Biol. Chem. 2005, 280:20340-20348.
26. Nam S., Buettner R., Turkson J., Kim D., Cheng J.Q., Muehlbeyer S., Hippe F., Vatter S., Merz K.H., Eisenbrand G., Jove R. Indirubin derivatives inhibit Stat3 signalling and induce apoptosis in human cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:5998-6003.
27. Nguyen L.P., Bradfield C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 2008, 21:102-116.
28. Nioi P., Hayes J.D. Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors. Mutat. Res. 2004, 555:149-171.
29. Nishiumi S., Yamamoto N., Kodoi R., Fukuda I., Yoshida K., Ashida H. Antagonistic and agonistic effects of indigoids on the transformation of an aryl hydrocarbon receptor. Arch. Biochem. Biophys. 2008, 470:187-199.
30. Okey A.B., Riddick D.S., Harper P.A. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 1994, 70:1-22.
31. Pollenz R.S. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem. Biol. Interact. 2002, 141:41-61.
32. Puga A., Ma C., Marlowe J.L. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 2009, 77:713-722.
33. Shafritz D.A., Dabeva M.D. Liver stem cells and model systems for liver repopulation. J. Hepatol. 2002, 36:552-564.
34. Spink B.C., Hussain M.M., Katz B.H., Eisele L., Spink D.C. Transient induction of cytochromes P450 1A1 and 1B1 in MCF-7 human breast cancer cells by indirubin. Biochem. Pharmacol. 2003, 66:2313-2321.
35. Sugihara K., Kitamura S., Yamada T., Okayama T., Ohta S., Yamashita K., Yasuda M., Fujii-Kuriyama Y., Saeki K., Matsui S., Matsuda T. Aryl hydrocarbon receptor-mediated induction of microsomal drug-metabolizing enzyme activity by indirubin and indigo. Biochem. Biophys. Res. Commun. 2004, 318:571-578.
36. Sugihara K., Okayama T., Kitamura S., Yamashita K., Yasuda M., Miyairi S., Minobe Y., Ohta S. Comparative study of aryl hydrocarbon receptor ligand activities of six chemicals in vitro and in vivo. Arch. Toxicol. 2008, 82:5-11.
37. Vondráček J., Švihálková-Šindlerová L., Pěnčíková K., Krčmář P., Andrysík Z., Chramostová K., Marvanová S., Valovičová Z., Kozubík A., Gábelová A., Machala M. 7H-Dibenzo[c,g]carbazole and 5,9-dimethyldibenzo[c,g]carbazole exert multiple toxic events contributing to tumor promotion in rat liver epithelial 'stem-like' cells. Mutat. Res. 2006, 596:43-56.
38. Weiss C., Faust D., Schreck I., Ruff A., Farwerck T., Melenberg A., Schneider S., Oesch-Bartlomowicz B., Zatloukalová J., Vondráček J., Oesch F., Dietrich C. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 2008, 27:2198-2207.
39. Weiss C., Kolluri S.K., Kiefer F., Göttlicher M. Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Exp. Cell Res. 1996, 226:154-163.
40. Wiebel F.J., Klose U., Kiefer F. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in vitro: H4IIEC3-derived 5L hepatoma cells as a model system. Toxicol. Lett. 1991, 55:161-169.
41. Zatloukalová J., Švihálková-Šindlerová L., Kozubík A., Krčmář P., Machala M., Vondráček J. beta-Naphthoflavone and 3'-methoxy-4'-nitroflavone exert ambiguous effects on Ah receptor-dependent cell proliferation and gene expression in rat liver 'stem-like' cells. Biochem. Pharmacol. 2007, 73:1622-1634.